Determinants of ESWT time variability in patients with COPD

A. Stoffels (Nijmegen (GE), Netherlands), J. Peters (Nijmegen (GE), Netherlands), M. Klaassen (Nijmegen (GE), Netherlands), H. Van Helvoort (Nijmegen (GE), Netherlands), R. Meys (Horn (LI), Netherlands), P. Klijn (Hilversum (NH), Netherlands), C. Burtin (Hasselt, Belgium), W. Derave (Ghent, Belgium), F. Franssen (Horn (LI), Netherlands), M. Spruit (Horn (LI), Netherlands), B. Van Den Borst (Nijmegen (GE), Netherlands), H. Van Hees (Nijmegen (GE), Netherlands)

Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Stoffels (Nijmegen (GE), Netherlands), J. Peters (Nijmegen (GE), Netherlands), M. Klaassen (Nijmegen (GE), Netherlands), H. Van Helvoort (Nijmegen (GE), Netherlands), R. Meys (Horn (LI), Netherlands), P. Klijn (Hilversum (NH), Netherlands), C. Burtin (Hasselt, Belgium), W. Derave (Ghent, Belgium), F. Franssen (Horn (LI), Netherlands), M. Spruit (Horn (LI), Netherlands), B. Van Den Borst (Nijmegen (GE), Netherlands), H. Van Hees (Nijmegen (GE), Netherlands). Determinants of ESWT time variability in patients with COPD. 946

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Determinants of exacerbation rate in patients with stable COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 661s
Year: 2004

Determinants of exercise capacity in patients with COPD
Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance
Year: 2012


Determinants of exercise capacity in patients with COPD without other comorbidities
Source: Annual Congress 2012 - Exercise capacity: from elite athletes to severe impairment
Year: 2012

Variability in exacerbation frequency in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 264s
Year: 2002

Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study
Source: International Congress 2018 – COPD management
Year: 2018


Impact of roflumilast treatment on the rate and duration of exacerbations and overall steroid load in patients with COPD
Source: Annual Congress 2011 - COPD management
Year: 2011

The influence of NIV on the pulse wave velocity in patients with the exacerbation of COPD
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Assessment of exercise capacity in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 294s
Year: 2004

Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008

Evaluation of change in fatigue after pulmonary rehabilitation programme in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 96s
Year: 2007

Assessing the burden of repeated exacerbations among COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 64s
Year: 2004

Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Individual variation in the time course of symptoms during exercise in COPD
Source: Annual Congress 2010 - Thoracic dynamics and dyspnoea on exercise
Year: 2010


Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015

Predictors of survival in severe COPD patients initiated on chronic NIV
Source: International Congress 2016 – New horizons for noninvasive ventilation in acute and chronic settings
Year: 2016

Impact of home hospitalization on treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 207s
Year: 2001

Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Impact of onset time in patients with asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 480s
Year: 2003

Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Predictors of benefit persistence after 6 months from a pulmonary rehabilitation programme in moderate-severe COPD patients
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008